
---

## Phase 178: Autonomous ADC Drug-to-Antibody Ratio (DAR) Optimization & Aggregation Predictor Engine
**Status**: ?? COMPLETE

**Goal**: In-silico antibody-drug conjugate (ADC) DAR profiling, Poisson/Binomial species resolution, and formulation aggregation stability simulation.

### Deliverables
- [x] ADC DAR optimization schema (dc_dar_opt_studies, dc_dar_species_distributions, dc_dar_aggregation_metrics)
- [x] High-performance async repository (ADCDAROptimizationRepository)
- [x] In-silico DAR optimization and aggregation kinetics simulator (ADCDAROptimizationEngine)
- [x] RESTful API endpoints (/api/v1/adc-dar-optimization/simulate, /api/v1/adc-dar-optimization/studies)
- [x] Interactive web studio (ADCDAROptimizationStudioPage.tsx)
- [x] 100% automated test coverage across database, research engine, and API layer
